In people with type 2 diabetes or specific cardiovascular risk factors, these can include improvements in insulin sensitivity, reduction in inflammatory markers, favourable effects on lipid profiles (particularly triglycerides), and potential cardiovascular benefits
Because a large number of comparisons were performed on the relative abundance data, main effect results from these analyses also underwent a BenjaminiHochberg false discovery rate (FDR) correction for multiple comparisons, and instances where a result was significant after this correction have been duly noted
But its not just foodservice junk food retailers will need to revamp their approach too, with research showing that nearly a third of American GLP-1 drug users are eating fewer carbs and snacks, 38% are reducing their fat intake, and 45% are consuming less sugar than before
Short answer: According to the company's FAQ at the time of publication, cancellation is not available once your selected program term has begun
This synergistic benefit is particularly pronounced in patients with baseline HbA1c above 8.5% or those with overweight or obesity
As GLP-1 shortages, counterfeit concerns, and affordability debates escalate, Novos pricing initiative is not only a commercial strategy but also a signal to policymakers that the industry is adapting.